{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:23:12Z","timestamp":1791328992183,"version":"4.3.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"CON-NANO\/CAPES, CNPq\/MCT, CNANO, FAPESP","award":["08-53719-4"],"award-info":[{"award-number":["08-53719-4"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.exppara.2013.07.008","type":"journal-article","created":{"date-parts":[[2013,7,24]],"date-time":"2013-07-24T18:32:37Z","timestamp":1374690757000},"page":"217-222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Leishmanicidal activity of amphotericin B encapsulated in PLGA\u2013DMSA nanoparticles to treat cutaneous leishmaniasis in C57BL\/6 mice"],"prefix":"10.1016","volume":"135","author":[{"given":"Ricardo Fontoura","family":"de Carvalho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ieler Ferreira","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Luisa","family":"Miranda-Vilela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"de Souza Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ol\u00edmpia Paschoal","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9bora","family":"de Oliveira Cintra e Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f4nio Cl\u00e1udio","family":"Tedesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zulmira Guerrero Marques","family":"Lacava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f4nia Nair","family":"B\u00e1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raimunda Nonata Ribeiro","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exppara.2013.07.008_b0005","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/jac\/dkn539","article-title":"Amphotericin B in poly(lactic-co-glycolic acid) (PLGA) and dimercaptosuccinic acid (DMSA) nanoparticles against paracoccidioidomycosis","volume":"63","author":"Amaral","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.exppara.2013.07.008_b0010","first-page":"301","article-title":"Optimizing efficacy of Amphotericin B through nanomodification","volume":"2","author":"Barratt","year":"2007","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.exppara.2013.07.008_b0015","first-page":"79","article-title":"Propriedades magn\u00e9ticas e biocompat\u00edveis de nanocomp\u00f3sitos para utiliza\u00e7\u00e3o em magneto-hipertermia","volume":"4","author":"Castro","year":"2010","journal-title":"Rev. Bras. Fis. Med."},{"key":"10.1016\/j.exppara.2013.07.008_b0020","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0001-706X(02)00238-3","article-title":"Leishmania model for microbial virulence: the relevance of parasite multiplication and pathoantigenicity","volume":"85","author":"Chang","year":"2003","journal-title":"Acta Trop."},{"key":"10.1016\/j.exppara.2013.07.008_b0025","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1590\/S0037-86822008000400022","article-title":"Estudo comparativo entre miltefosina oral e antimoniato de N-metil glucamina parenteral no tratamento da leishmaniose experimental causada por Leishmania (Leishmania) amazonensis","volume":"41","author":"Costa Filho","year":"2008","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.exppara.2013.07.008_b0030","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1109\/TMAG.2003.815540","article-title":"Stability of citrate-coated magnetite and cobalt-ferrite nanoparticles under laser irradiation: a Raman spectroscopy investigation","volume":"39","author":"da Silva","year":"2003","journal-title":"IEEE Trans. Magn."},{"key":"10.1016\/j.exppara.2013.07.008_b0035","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.addr.2009.11.017","article-title":"Nanotechnology-based systems for the treatment and prevention of HIV\/AIDS","volume":"62","author":"das Neves","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.exppara.2013.07.008_b0040","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.actatropica.2010.04.007","article-title":"The influence of ecto-nucleotidases on Leishmania amazonensis infection and immune response in C57B\/6 mice","volume":"115","author":"de Souza","year":"2010","journal-title":"Acta Trop."},{"key":"10.1016\/j.exppara.2013.07.008_b0045","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives","volume":"27","author":"Desjeux","year":"2004","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.exppara.2013.07.008_b0050","doi-asserted-by":"crossref","first-page":"458128","DOI":"10.1155\/2011\/458128","article-title":"Encapsulation of protein-polysaccharide hip complex in polymeric nanoparticles","volume":"2011","author":"Gaudana","year":"2011","journal-title":"J. Drug. Deliv."},{"key":"10.1016\/j.exppara.2013.07.008_b0055","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ejps.2009.02.021","article-title":"Amphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristics","volume":"37","author":"Jung","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.exppara.2013.07.008_b0060","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.addr.2011.03.008","article-title":"Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery","volume":"63","author":"Kumar","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.exppara.2013.07.008_b0065","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1586\/14760584.7.8.1277","article-title":"Cutaneous leishmaniasis: progress towards a vaccine","volume":"7","author":"Launois","year":"2008","journal-title":"Expert. Rev. Vaccines"},{"key":"10.1016\/j.exppara.2013.07.008_b0070","unstructured":"Loustaunau V.M., 2011. A treatment option in the fields of oncology and infectious disease. http:\/\/www.placidway.com\/article\/393\/Medical_Hyperthermia, 2011."},{"key":"10.1016\/j.exppara.2013.07.008_b0075","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.tmaid.2006.09.004","article-title":"Cutaneous leishmaniasis treatment","volume":"5","author":"Minodier","year":"2007","journal-title":"Travel Med. Infect. Dis."},{"key":"10.1016\/j.exppara.2013.07.008_b0080","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","article-title":"Advances in leishmaniasis","volume":"366","author":"Murray","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.exppara.2013.07.008_b0085","first-page":"51","article-title":"Estudo hospitalar da leishmaniose tegumentar americana (LTA): epidemiologia e tratamento","volume":"76","author":"Nogueira","year":"2001","journal-title":"An. Bras. Dermatol."},{"key":"10.1016\/j.exppara.2013.07.008_b0090","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4161\/hv.5.5.7607","article-title":"Vaccines and vaccination strategies against human cutaneous leishmaniasis","volume":"5","author":"Okwor","year":"2009","journal-title":"Hum. Vaccine"},{"key":"10.1016\/j.exppara.2013.07.008_b0095","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1166\/jbn.2011.1332","article-title":"AmbiOnp: solid lipid nanoparticles of amphotericin B for oral administration","volume":"7","author":"Patel","year":"2011","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.exppara.2013.07.008_b0100","first-page":"109","article-title":"Investigation of a magnetohyperthermia system efficacy","author":"Portilho","year":"2011","journal-title":"J. Appl. Phys."},{"key":"10.1016\/j.exppara.2013.07.008_b0105","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.exppara.2010.08.004","article-title":"Leishmania amazonensis META2 protein confers protection against heat shock and oxidative stress","volume":"127","author":"Ramos","year":"2011","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2013.07.008_b0110","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1517\/17425247.5.7.805","article-title":"Drug delivery systems against leishmaniasis? Still an open question","volume":"5","author":"Romero","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.exppara.2013.07.008_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/389640","article-title":"The application of thermosensitive nanocarriers in controlled drug delivery","author":"Shao","year":"2011","journal-title":"J. Nanomat."},{"key":"10.1016\/j.exppara.2013.07.008_b0120","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-3024.2009.01116.x","article-title":"Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis","volume":"31","author":"Silveira","year":"2009","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.exppara.2013.07.008_b0125","first-page":"272","article-title":"Structural stability study of cobalt ferrite-based nanoparticle using micro Raman spectroscopy","volume":"3","author":"Soler","year":"2004","journal-title":"J. Magn. Magn. Mater."},{"key":"10.1016\/j.exppara.2013.07.008_b0130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1590\/S0074-02762011000100004","article-title":"Immune and inflammatory responses to Leishmania amazonensis isolated from different clinical forms of human leishmaniasis in CBA mice","volume":"106","author":"Souza","year":"2011","journal-title":"Mem. Inst. Oswaldo Cruz."},{"key":"10.1016\/j.exppara.2013.07.008_b0135","first-page":"951","article-title":"Laboratory diagnosis of visceral Leishmaniasis","volume":"9","author":"Sundar","year":"2002","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.exppara.2013.07.008_b0140","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6673-2-16","article-title":"Nanotechnology-based drug delivery systems","volume":"2","author":"Suri","year":"2007","journal-title":"J. Occup. Med. Toxicol."},{"key":"10.1016\/j.exppara.2013.07.008_b0145","doi-asserted-by":"crossref","unstructured":"The Lancet Oncology, 2013. Cancer treatment and antimicrobial resistance. http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470204513701451.","DOI":"10.1016\/S1470-2045(13)70145-1"},{"key":"10.1016\/j.exppara.2013.07.008_b0150","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2147\/nano.2006.1.4.417","article-title":"Optimizing efficacy of amphotericin B through nanomodification","volume":"1","author":"Vyas","year":"2006","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.exppara.2013.07.008_b0155","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1128\/IAI.00658-10","article-title":"Differential microbicidal effects of human histone proteins H2A and H2B on Leishmania Promastigotes and Amastigotes","volume":"79","author":"Wang","year":"2011","journal-title":"Infect. Immun."},{"key":"10.1016\/j.exppara.2013.07.008_b0160","first-page":"68","article-title":"In vitro sensitivity of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis Brazilian isolates to meglumine antimoniate and amphotericin B","volume":"15","author":"Zauli-Nascimento","year":"2010","journal-title":"Trop. Med. Int. Health."},{"key":"10.1016\/j.exppara.2013.07.008_b0165","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/03639040600975147","article-title":"Preparation of azithromycin nanosuspensions by high pressure homogenization and its physicochemical characteristics studies","volume":"33","author":"Zhang","year":"2007","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.exppara.2013.07.008_b0170","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2174\/092986710790416290","article-title":"Development of nanoparticles for antimicrobial drug delivery","volume":"17","author":"Zhang","year":"2010","journal-title":"Curr. Med. Chem."}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448941300194X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448941300194X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T08:23:59Z","timestamp":1563524639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448941300194X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S001448941300194X"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2013.07.008","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leishmanicidal activity of amphotericin B encapsulated in PLGA\u2013DMSA nanoparticles to treat cutaneous leishmaniasis in C57BL\/6 mice","name":"articletitle","label":"Article Title"},{"value":"Experimental Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exppara.2013.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}